All financings
COMPANY TRANSACTIONS

Cuprina Holdings (Cayman) LTD.

CUPRNasdaqMedical - Instruments & Supplies

Deal details

1 transaction in the database

TRANSACTION REPORT · SEC DISCLOSURES
Gross proceeds$5.0M
Offering price$1.15
Discount to prior close60.8%
Warrant coverage—
Placement agent / underwriterR. F. Lafferty & Co., Inc.

Transaction overview

01

Cuprina Holdings (Cayman) LTD completed a $5.0M underwritten public offering at $1.15 per share. R. F. Lafferty & Co., Inc. acted as underwriter for the financing.

Financing type
Underwritten Public Offering
Announcement date
Sep 16, 2026
Pricing date
Sep 16, 2026
Closing date
Sep 17, 2026
Filing date
Sep 18, 2026
Status
Closed
Market cap before announcement
$7.9M
Prior closing price
$2.93
Raise as % of market cap
63.3%

Market data · FMP

Historical market cap
$7,856,062.5
Market date
Sep 15, 2026
Closing price
$2.93
Latest reported shares outstanding
2,681,250
Latest reported float shares
920,634
Share-data date
Sep 29, 2026

Market cap and closing price are from FMP for the date shown. Shares are FMP’s latest available snapshot, dated separately. Updated Sep 30, 2026.

Financial Modeling Prep ↗

Financing terms

02

Equity

Common shares issued
4,322,489
Price per share
$1.15
Pre-funded warrants
—
Pre-financing shares disclosed in filing
—
Shares outstanding after financing
—

Fees & transaction economics

03
Placement agent / underwriting fee
7%
Agent fee amount
$347,900
Management fee
—
Other offering expenses (estimated)
—
Net proceeds (estimated)
—
Net proceeds as % of gross
—

Fee amounts reflect disclosed inputs. Unknown expense components are not assumed to be zero.

Representative’s Warrants We have agreed to issue R. F. Lafferty & Co., Inc. warrants to purchase a number of Class A Ordinary Shares equal to 4.0% of the total number of Class A Ordinary Shares sold in this offering as additional consideration for its services. The Representative’s Warrants will have an exercise price equal to 110% of the public offering price of Class A Ordinary Shares sold in this offering and will be exercisable beginning six months following the commencement of sales of the public securities in this offering and for a period of four-and-a-half years thereafter, and will contain customary “cashless” exercise and registration rights provisions.

Transaction participants

04
Investor names: —

Source documents

05

SEC filings, exhibits and attributed market data. The report separates disclosed facts, calculated metrics, and unknown terms.

424B4 · Cuprina Holdings (Cayman) LTDSEC filing · Sep 16, 2026
Open source ↗
EX-1.1 · Cuprina Holdings (Cayman) LTDSEC filing · Sep 18, 2026
Open source ↗
EX-4.1 · Cuprina Holdings (Cayman) LTDSEC filing · Sep 18, 2026
Open source ↗
EX-99.1 · Cuprina Holdings (Cayman) LTDSEC filing · Sep 18, 2026
Open source ↗
EX-99.2 · Cuprina Holdings (Cayman) LTDSEC filing · Sep 18, 2026
Open source ↗
6-K · Cuprina Holdings (Cayman) LTDSEC filing · Sep 18, 2026
Open source ↗
FMP historical market data · CUPRMarket data · Sep 15, 2026
Open source ↗
SEC deal terms · FMP market data where available · Initial research sample, not complete market coverage. AI-assisted source review; original evidence is available in each report. Names and tickers reflect the transaction date. A dash (—) means the value is unavailable.